RSS Feeds
Statins and Nasal Polyps
- Caterina Bucca, MD;
- Andrea Marsico, MD;
- Erika Panaro, MD;
- Patrizia Bigo, MD; and
- Luisa Brussino, MD
- From University of Turin, 10128 Turin, Italy, and St. Giovanni Battista Hospital; 10126 Turin, Italy.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: Chemotaxis of eosinophils is the crucial event in the development of nasal polyposis related to chronic hyperplastic eosinophilic …
